Michael Jay Ross

This profile gathers the share dealings of Michael Jay Ross across 3 companies, led by Sutro Biopharma, Inc., X4 Pharmaceuticals, Inc and IVERIC bio, Inc. Between 1 June 2016 and 1 October 2018, the trades on record add up to 31 filings.

The open-market record is one-sided, with 2 purchases worth €4.3M and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 2 option exercises.

Most recently, on 1 October 2018, the filings show a transaction in Sutro Biopharma, Inc. The last insider purchase was made public on 20 November 2017, 3,276 days ago. The median gap between trade and publication is zero days: most filings appear on the same day. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.